These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35220356)

  • 21. The Treatment of Disruptive Vocalization in Dementia (Behavioral and Psychological Symptoms of Dementia) With Electroconvulsive Therapy: A Case Series.
    Lau TE; Babani PK; McMurray LA
    J ECT; 2017 Jun; 33(2):e9-e13. PubMed ID: 28009620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
    Schmidt LS; Petersen JZ; Vinberg M; Hageman I; Olsen NV; Kessing LV; Jørgensen MB; Miskowiak KW
    Trials; 2018 Apr; 19(1):234. PubMed ID: 29673379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial.
    Brakemeier EL; Merkl A; Wilbertz G; Quante A; Regen F; Bührsch N; van Hall F; Kischkel E; Danker-Hopfe H; Anghelescu I; Heuser I; Kathmann N; Bajbouj M
    Biol Psychiatry; 2014 Aug; 76(3):194-202. PubMed ID: 24462229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electroconvulsive therapy for older adult patients with major depressive disorder: a systematic review of randomized controlled trials.
    Dong M; Zhu XM; Zheng W; Li XH; Ng CH; Ungvari GS; Xiang YT
    Psychogeriatrics; 2018 Nov; 18(6):468-475. PubMed ID: 30073725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of electroconvulsive therapy in the treatment of bipolar disorder: a systematic review.
    Versiani M; Cheniaux E; Landeira-Fernandez J
    J ECT; 2011 Jun; 27(2):153-64. PubMed ID: 20562714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electroconvulsive therapy in adolescents with intellectual disability and severe self-injurious behavior and aggression: a retrospective study.
    Consoli A; Cohen J; Bodeau N; Guinchat V; Wachtel L; Cohen D
    Eur Child Adolesc Psychiatry; 2013 Jan; 22(1):55-62. PubMed ID: 22923049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintenance Electroconvulsive Therapy for Agitation and Self Injurious Behaviors in Autism Spectrum Disorder.
    Adıgüzel Akman Ö; Kahraman Girgeç S; Çelik S; Çakır Kardeş V; Atasoy N
    Turk Psikiyatri Derg; 2021; 32(1):65-69. PubMed ID: 34181747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.
    Wilcock GK; Ballard CG; Cooper JA; Loft H
    J Clin Psychiatry; 2008 Mar; 69(3):341-8. PubMed ID: 18294023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electroconvulsive therapy for the depressed elderly.
    Van der Wurff FB; Stek ML; Hoogendijk WL; Beekman AT
    Cochrane Database Syst Rev; 2003; 2003(2):CD003593. PubMed ID: 12804479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electroconvulsive therapy in individuals with dementia/major NCD presenting with behavioral symptoms: a systematic review.
    Bachu AK; Kotapati VP; Kainth T; Patel R; Youssef NA; Tampi RR
    Int Psychogeriatr; 2023 May; ():1-16. PubMed ID: 37170574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
    Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
    J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease.
    Liu CS; Chau SA; Ruthirakuhan M; Lanctôt KL; Herrmann N
    CNS Drugs; 2015 Aug; 29(8):615-23. PubMed ID: 26271310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrabrief Right Unilateral Electroconvulsive Therapy for the Treatment of the Neuropsychiatric Symptoms of Dementia with Lewy Bodies.
    Hermida AP; Sterina E; Schwab PP; Browning CM; Chapman HM; Marques Pinheiro AP; Mori N
    J ECT; 2022 Mar; 38(1):39-44. PubMed ID: 34739421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to Electroconvulsive Therapy in Patients With Autism Spectrum Disorder and Intractable Challenging Behaviors Associated With Symptoms of Catatonia.
    Sajith SG; Liew SF; Tor PC
    J ECT; 2017 Mar; 33(1):63-67. PubMed ID: 27428481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study design.
    Devanand DP; Strickler JG; Huey ED; Crocco E; Forester BP; Husain MM; Vahia IV; Andrews H; Wall MM; Pelton GH
    Contemp Clin Trials; 2018 Aug; 71():33-39. PubMed ID: 29859917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electroconvulsive therapy for treatment-resistant schizophrenia.
    Sinclair DJ; Zhao S; Qi F; Nyakyoma K; Kwong JS; Adams CE
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011847. PubMed ID: 30888709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial.
    Devanand DP; Crocco E; Forester BP; Husain MM; Lee S; Vahia IV; Andrews H; Simon-Pearson L; Imran N; Luca L; Huey ED; Deliyannides DA; Pelton GH
    Am J Geriatr Psychiatry; 2022 Jan; 30(1):32-42. PubMed ID: 34059401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Low Dose of Ketamine on Learning Memory Function in Patients Undergoing Electroconvulsive Therapy-A Randomized, Double-Blind, Controlled Clinical Study.
    Chen Q; Min S; Hao X; Peng L; Meng H; Luo Q; Chen J; Li X
    J ECT; 2017 Jun; 33(2):89-95. PubMed ID: 27828927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial.
    Anderson IM; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Elwell C; Hayden K; Holland F; Karim S; Loo C; Lowe J; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; McAllister-Williams RH;
    Lancet Psychiatry; 2017 May; 4(5):365-377. PubMed ID: 28359862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.